{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:32:17Z","timestamp":1768879937862,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40261-025-01500-4","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:10:49Z","timestamp":1762189849000},"page":"57-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends of Opioids and Nefopam Use Among French Children: A Population-Based Study From 2009 to 2023"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1041-8926","authenticated-orcid":false,"given":"Sandrella","family":"Hamdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0051-0273","authenticated-orcid":false,"given":"Pierre","family":"Pinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-4742","authenticated-orcid":false,"given":"Jean-marc","family":"Tr\u00e9luyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-5602","authenticated-orcid":false,"given":"Florentia","family":"Kaguelidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-3571","authenticated-orcid":false,"given":"Laurent","family":"Chouchana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7505-3867","authenticated-orcid":false,"given":"Violaine","family":"Smail-Faugeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"1500_CR1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/1471-2458-11-770","volume":"11","author":"DS Goldberg","year":"2011","unstructured":"Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011;11:770.","journal-title":"BMC Public Health"},{"key":"1500_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0304-3959(02)00258-0","volume":"99","author":"MS Lidow","year":"2002","unstructured":"Lidow MS. Long-term effects of neonatal pain on nociceptive systems - ScienceDirect. Pain. 2002;99:377\u201383.","journal-title":"Pain"},{"key":"1500_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00004703-199908000-00008","volume":"20","author":"FL Porter","year":"1999","unstructured":"Porter FL, Grunau RE, Anand KJS. Long-term effects of pain in infants. J Dev Behav Pediatr. 1999;20:253.","journal-title":"J Dev Behav Pediatr"},{"key":"1500_CR4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJM198711193172105","volume":"317","author":"KJ Anand","year":"1987","unstructured":"Anand KJ, Hickey PR. Pain and its effects in the human neonate and fetus. N Engl J Med. 1987;317:1321\u20139.","journal-title":"N Engl J Med"},{"key":"1500_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0304-3959(87)90034-0","volume":"31","author":"A Gauvain-Piquard","year":"1987","unstructured":"Gauvain-Piquard A, Rodary C, Rezvani A, et al. Pain in children aged 2\u20136 years: a new observational rating scale elaborated in a pediatric oncology unit\u2013preliminary report. Pain. 1987;31:177\u201388.","journal-title":"Pain"},{"key":"1500_CR6","unstructured":"HAS. Prise en charge m\u00e9dicamenteuse de la douleur chez l\u2019enfant\u202f: alternatives \u00e0 la cod\u00e9ine. 2016."},{"key":"1500_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00540-020-02767-x","volume":"34","author":"N Gai","year":"2020","unstructured":"Gai N, Naser B, Hanley J, et al. A practical guide to acute pain management in children. J Anesth. 2020;34:421\u201333.","journal-title":"J Anesth"},{"key":"1500_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/jamapediatrics.2021.1832","volume":"175","author":"MH Renny","year":"2021","unstructured":"Renny MH, Yin HS, Jent V, et al. Temporal trends in opioid prescribing practices in children, adolescents, and younger adults in the US from 2006 to 2018. JAMA Pediatr. 2021;175:1043\u201352.","journal-title":"JAMA Pediatr"},{"key":"1500_CR9","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMp1302454","volume":"368","author":"JA Racoosin","year":"2013","unstructured":"Racoosin JA, Roberson DW, Pacanowski MA, et al. New evidence about an old drug\u2014risk with codeine after adenotonsillectomy. N Engl J Med. 2013;368:2155\u20137.","journal-title":"N Engl J Med"},{"key":"1500_CR10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s40264-022-01214-y","volume":"45","author":"K Plueschke","year":"2022","unstructured":"Plueschke K, Flynn R, Hedenmalm K, et al. Prescribing patterns of codeine and alternative medicines in children in Europe. Drug Saf. 2022;45:1069\u201381.","journal-title":"Drug Saf"},{"key":"1500_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2009.082974","author":"K De","year":"2010","unstructured":"De K, Ak F. Fatal nefopam overdose. Emerg Med J EMJ. 2010. https:\/\/doi.org\/10.1136\/emj.2009.082974. (Epub ahead of print May 2010).","journal-title":"Emerg Med J EMJ"},{"key":"1500_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/jat\/bkv036","volume":"39","author":"LN Seetohul","year":"2015","unstructured":"Seetohul LN, De Paoli G, Drummond G, et al. Nefopam hydrochloride: a fatal overdose. J Anal Toxicol. 2015;39:486\u20139.","journal-title":"J Anal Toxicol"},{"key":"1500_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/bja\/83.3.501","volume":"83","author":"SC Urwin","year":"1999","unstructured":"Urwin SC, Smith HS. Fatal nefopam overdose. Br J Anaesth. 1999;83:501\u20132.","journal-title":"Br J Anaesth"},{"key":"1500_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559\u201374.","journal-title":"Annu Rev Public Health"},{"key":"1500_CR15","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1186\/s12889-025-23283-1","volume":"25","author":"M Fang","year":"2025","unstructured":"Fang M, Zhang Q, Peng J, et al. Global, regional, and national burden of opioid use disorder from 1990 to 2021: a statistical analysis of incidence, mortality, and disability-adjusted life years. BMC Public Health. 2025;25:1988.","journal-title":"BMC Public Health"},{"key":"1500_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/pds.4233","volume":"26","author":"J Bezin","year":"2017","unstructured":"Bezin J, Duong M, Lassalle R, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954\u201362.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1500_CR17","unstructured":"Dossier th\u00e9matique\u2014Classes d\u2019\u00e2ge des enfants et adolescents. ANSM. https:\/\/ansm.sante.fr\/dossiers-thematiques\/medicaments-en-pediatrie-enfants-et-adolescents\/classes-dage-des-enfants-et-adolescents. Accessed 14 Oct 2025."},{"key":"1500_CR18","unstructured":"Joinpoint Regression Program. https:\/\/surveillance.cancer.gov\/joinpoint\/. Accessed 24 Oct 2024."},{"key":"1500_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335\u201351.","journal-title":"Stat Med"},{"key":"1500_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20156493","volume":"20","author":"G De Clifford-Faug\u00e8re","year":"2023","unstructured":"De Clifford-Faug\u00e8re G, Nguena Nguefack HL, Choini\u00e8re M, et al. Trends in prescription chronic pain medication use before and during the first wave of the COVID-19 pandemic in Qu\u00e9bec, Canada: an interrupted time series analysis. Int J Environ Res Public Health. 2023;20:6493.","journal-title":"Int J Environ Res Public Health"},{"key":"1500_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000891","volume":"6","author":"A Lacasse","year":"2021","unstructured":"Lacasse A, Pag\u00e9 MG, Dassieu L, et al. Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 pan-Canadian study. PAIN Rep. 2021;6:e891.","journal-title":"PAIN Rep"},{"key":"1500_CR22","doi-asserted-by":"publisher","first-page":"215013192210769","DOI":"10.1177\/21501319221076926","volume":"13","author":"S Rikin","year":"2022","unstructured":"Rikin S, Perez HR, Zhang C, et al. Changes in outpatient opioid prescribing during the COVID-19 pandemic: an interrupted time series analysis. J Prim Care Community Health. 2022;13:21501319221076930.","journal-title":"J Prim Care Community Health"},{"key":"1500_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/papr.13197","volume":"23","author":"LF Valladales-Restrepo","year":"2023","unstructured":"Valladales-Restrepo LF, Gaviria-Mendoza A, Machado-Duque ME, et al. Chronic pain and continuity of analgesic treatment during the COVID-19 pandemic. Pain Pract. 2023;23:359\u201367.","journal-title":"Pain Pract"},{"key":"1500_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293621","volume":"18","author":"J Zhang","year":"2023","unstructured":"Zhang J, Nalliah RP, Waljee JF, et al. Association between the COVID-19 outbreak and opioid prescribing by U.S. dentists. PLoS ONE. 2023;18:e0293621.","journal-title":"PLoS ONE"},{"key":"1500_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.28159","author":"N Gisev","year":"2023","unstructured":"Gisev N, Buizen L, Hopkins RE, et al. Five-year trajectories of prescription opioid use. JAMA Netw Open. 2023. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.28159.","journal-title":"JAMA Netw Open"},{"key":"1500_CR26","doi-asserted-by":"publisher","first-page":"e753","DOI":"10.1542\/peds.2014-2673","volume":"135","author":"G Orliaguet","year":"2015","unstructured":"Orliaguet G, Hamza J, Couloigner V, et al. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol. Pediatrics. 2015;135:e753\u20135.","journal-title":"Pediatrics"},{"key":"1500_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00148","author":"F Rodieux","year":"2018","unstructured":"Rodieux F, Vutskits L, Posfay-Barbe KM, et al. When the safe alternative is not that safe: tramadol prescribing in children. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.00148.","journal-title":"Front Pharmacol"},{"key":"1500_CR28","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387:1644\u201356.","journal-title":"Lancet"},{"key":"1500_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182413316","volume":"18","author":"S Choufi","year":"2021","unstructured":"Choufi S, Mounier S, Merlin E, et al. Opioid analgesic prescription in French children: a national population-based study. Int J Environ Res Public Health. 2021;18:13316.","journal-title":"Int J Environ Res Public Health"},{"key":"1500_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4836","author":"K Hedenmalm","year":"2019","unstructured":"Hedenmalm K, et al. A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiol Drug Saf. 2019. https:\/\/doi.org\/10.1002\/pds.4836.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1500_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejp.1291","volume":"23","author":"C Chenaf","year":"2019","unstructured":"Chenaf C, Kabor\u00e9 J-L, Delorme J, et al. Prescription opioid analgesic use in France: trends and impact on morbidity-mortality. Eur J Pain. 2019;23:124\u201334.","journal-title":"Eur J Pain"},{"key":"1500_CR32","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ejp.632","volume":"19","author":"M Mahic","year":"2015","unstructured":"Mahic M, Fredheim OM, Borchgrevink PC, et al. Use of prescribed opioids by children and adolescents: differences between Denmark, Norway and Sweden: use of prescribed opioids by children and adolescents. Eur J Pain. 2015;19:1095\u2013100.","journal-title":"Eur J Pain"},{"key":"1500_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ejp.520","volume":"19","author":"A Ruscitto","year":"2015","unstructured":"Ruscitto A, Smith BH, Guthrie B. Changes in opioid and other analgesic use 1995\u20132010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland. Eur J Pain Lond Engl. 2015;19:59\u201366.","journal-title":"Eur J Pain Lond Engl"},{"key":"1500_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.therap.2021.01.058","volume":"76","author":"B Revol","year":"2021","unstructured":"Revol B, Delorme J, Jouanjus \u00c9, et al. Trente ans d\u2019abus de n\u00e9fopam en France. Therapies. 2021;76:527\u201337.","journal-title":"Therapies"},{"key":"1500_CR35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/0300060516650783","volume":"44","author":"HS Jin","year":"2016","unstructured":"Jin HS, Kim YC, Yoo Y, et al. Opioid sparing effect and safety of nefopam in patient controlled analgesia after laparotomy: a randomized, double blind study. J Int Med Res. 2016;44:844\u201354.","journal-title":"J Int Med Res"},{"key":"1500_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3821\/145.6.cpj276","volume":"145","author":"C Wong","year":"2012","unstructured":"Wong C, Lau E, Palozzi L, et al. Pain management in children: Part 2\u2014a transition from codeine to morphine for moderate to severe pain in children. Can Pharm J Revue des Pharmaciens du Canada. 2012;145:276-279.e1.","journal-title":"Can Pharm J Revue des Pharmaciens du Canada"},{"key":"1500_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1460-9592.1997.tb00488.x","volume":"7","author":"T Kart","year":"1997","unstructured":"Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: Part 2\u2013clinical use. Paediatr Anaesth. 1997;7:93\u2013101.","journal-title":"Paediatr Anaesth"},{"key":"1500_CR38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1213\/00000539-199310000-00007","volume":"77","author":"AM Lynn","year":"1993","unstructured":"Lynn AM, Nespeca MK, Opheim KE, et al. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg. 1993;77:695\u2013701.","journal-title":"Anesth Analg"},{"key":"1500_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0304-3959(00)00313-4","volume":"88","author":"AM Lynn","year":"2000","unstructured":"Lynn AM, Nespeca MK, Bratton SL, et al. Intravenous morphine in postoperative infants: intermittent bolus dosing versus targeted continuous infusions. Pain. 2000;88:89\u201395.","journal-title":"Pain"},{"key":"1500_CR40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0205","volume":"137","author":"YT Yang","year":"2016","unstructured":"Yang YT, Chen B, Bennett CL. FDA approval of extended-release oxycodone for children with severe pain. Pediatrics. 2016;137:e20160205.","journal-title":"Pediatrics"},{"key":"1500_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00004583-200402000-00020","volume":"43","author":"DA Katz","year":"2004","unstructured":"Katz DA, Hays LR. Adolescent OxyContin abuse. J Am Acad Child Adolesc Psychiatry. 2004;43:231\u20134.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1500_CR42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/jama.2015.12346","volume":"314","author":"H Koh","year":"2015","unstructured":"Koh H. Community approaches to the opioid crisis. JAMA. 2015;314:1437\u20138.","journal-title":"JAMA"},{"key":"1500_CR43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S2352-4642(19)30329-3","volume":"3","author":"J Bell","year":"2019","unstructured":"Bell J, Paget SP, Nielsen TC, et al. Prescription opioid dispensing in Australian children and adolescents: a national population-based study. Lancet Child Adolesc Health. 2019;3:881\u20138.","journal-title":"Lancet Child Adolesc Health"},{"key":"1500_CR44","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1038\/s41598-019-40806-0","volume":"9","author":"I Dragomirescu","year":"2019","unstructured":"Dragomirescu I, Llorca J, G\u00f3mez-Acebo I, et al. A join point regression analysis of trends in mortality due to osteoporosis in Spain. Sci Rep. 2019;9:4264.","journal-title":"Sci Rep"},{"key":"1500_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","volume":"171","author":"T Gomes","year":"2011","unstructured":"Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686\u201391.","journal-title":"Arch Intern Med"},{"key":"1500_CR46","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ejpain.2008.11.006","volume":"13","author":"K Hamunen","year":"2009","unstructured":"Hamunen K, Paakkari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002\u20132006. Eur J Pain. 2009;13:954\u201362.","journal-title":"Eur J Pain"},{"key":"1500_CR47","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/j.1532-2149.2014.496.x","volume":"18","author":"C Zin","year":"2014","unstructured":"Zin C, Chen L-C, Knaggs R. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain. 2014;18:1343\u201351.","journal-title":"Eur J Pain"},{"key":"1500_CR48","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Fiche R\u00e9sum\u00e9 des Caract\u00e9ristiques du Produit\u2014Nefopam. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=62580656&typedoc=R. Accessed 20 Jul 2025."},{"key":"1500_CR49","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Fiche RCP\u2014Tramadol. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=66125684&typedoc=R. Accessed 20 Jul 2025."},{"key":"1500_CR50","unstructured":"European Medicines Agency. Codeine-containing medicines. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/codeine-containing-medicines. Accessed 20 Jul 2025."},{"key":"1500_CR51","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Fiche RCP\u2014Opium. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=62689634&typedoc=R. Accessed 20 Jul 2025."},{"key":"1500_CR52","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Fiche RCP\u2014Morphine. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=67877743&typedoc=R. Accessed 20 Jul 2025."},{"key":"1500_CR53","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Fiche RCP\u2014Oxycodone. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=61200108&typedoc=R. Accessed 20 Jul 2025."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01500-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-025-01500-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01500-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:37:28Z","timestamp":1768833448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-025-01500-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1500"],"URL":"https:\/\/doi.org\/10.1007\/s40261-025-01500-4","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Access to the SNDS was granted to the authors by the French decree no. 2021\u2013848. The study adhered to the principles of the Declaration of Helsinki and to the French law on biomedical research, and no informed consent from the patients was required. All data used are pseudonymized, with no possibility of referring back to the patients. In accordance with French regulations, observational studies conducted using anonymous medico-administrative data do not require ethics committee approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This study was based on anonymized data from the French national health data system (SNDS). In accordance with French regulations, individual consent to participate is not require for observational studies conducted using anonymous medico-administrative data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"This study was based on anonymized data from the French national health data system (SNDS), and individual consent for publication was not required\n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"The data that support the findings of this study are available on request from the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Dr Laurent Chouchana, and Profs. Jean-Marc Tr\u00e9luyer and Violaine Smail-Faugeron conceptualized and designed the study, analyzed data, drafted the initial manuscript, and critically reviewed and revised the manuscript. Drs Sandrella Hamdan and Pierre Pinson designed the data collection instruments, curated data, carried out the initial analyses, and critically reviewed and revised the manuscript. Prof Florentia Kaguelidou coordinated and supervised data collection, and critically reviewed and revised the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}